GDC-0449 (Vismodegib) is a potent, orally bioavailable, specific hedgehog pathway small-molecule inhibitor with IC50 of 3 nM. It blocks the activities of the Hedgehog-ligand cell surface receptor SMO and suppresses Hedgehog signaling [1].The hedgehog (HH) pathway, a key signaling pathway in embryological development, is normally inactive in differentiated cells, with the exception of roles in tissue maintenance and repair. Constitutive reactivation of the HH pathway via mutations and aberrant autocrine/paracrine HH ligand stimulation has been linked to a number of cancers5. GDC-0449 has been shown to target SMO with an EC50 of 2.8nmol/L on a human palatal mesenchymal cell line (HEPM) stably expressing a GLI-responsive luciferase reporter gene, and to induce rapid regression of the tumor and suppression of the hedgehog pathway in the Ptc1+/? murine medulloblastoma model. Furthermore, GDC-0449 inhibits the growth of primary pancreatic xenografts without non-specifically inhibiting pancreatic cell proliferation in vitro [1-3]. GDC-0449 is also an inhibitor of two multiple ATP-binding cassette (ABC) transporters, ABCG2/BCRP and ABCB1/Pgp, and is a mild inhibitor of ABCC1/MRP1. The overexpression of ABC transporters is associated with multidrug resistance. The IC50 values for inhibition of ABCG2 and Pgp were approximately 1.4 and 3.0 µM, respectively [4].
Technical information:
| Chemical Formula: | C19H14Cl2N2O3S | |
| CAS #: | 879085-55-9 | |
| Molecular Weight: | 421.3 | |
| Purity: | > 98% | |
| Appearance: | White | |
| Chemical Name: | 2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide | |
| Solubility: | Up to 100 mM in DMSO | |
| Synonyms: | GDC-0449, GDC0449, Vismodegib, Erivedge |
Shipping Condition: The product is shipped in a glass vial at ambient temperature.Storage condition: For longer shelf life, store solid powder at 4oC desiccated, or store DMSO solution at -20oC.
Reference:
| 1. | Robarge KD, et al. GDC-0449-a potent inhibitor of the hedgehog pathway. Bioorg Med Chem Lett. 2009. 19(19):5576-81. Pubmed ID:19716296 |
| 2. | Wong H, et al. Pharmacokinetic-pharmacodynamic analysis of vismodegib in preclinical models of mutational and ligand-dependent Hedgehog pathway activation. Clin Cancer Res. 2011.17(14):4682-92. Pubmed ID:21610148 |
| 3. | Rudin CM, et al. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med. 2009. 361(12):1173-8. Pubmed ID:19726761 |
| 4. | Zhang Y, Hedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2/BCRP and ABCB1/Pgp. Neoplasia. 2009. 11(1):96-101. Pubmed ID:21610148 |
Other Information:
Product Specification (pdf) MSDS (pdf) Certificate of Analysis is available upon request.
Cellagen的FlexiWash FW400自动膜/凝胶洗涤站设计用于自动Western blot膜洗涤和孵育过程。将蛋白质转移到膜上后，将膜加载到FlexiWash上以进行自动封闭，孵育和洗涤循环。用户只需要准备所需的试剂，启动印迹程序，然后让FW400进行其余操作即可。凭借独特的液体处理设计，FW400同时支持四个清洗/孵育过程，每个过程均可独立编程，并针对特定应用实现全自动。FW400也可用于蛋白质或DNA凝胶染色和脱色，或涉及重复液体处理和孵育周期的任何其他应用。
